fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Mutual Funds » Nippon India PHARMA Fund

Nippon India PHARMA Fund - G

NAV  ₹522.364 ↓ -0.57  (-0.11 %) as on 21 Jul 25

Scheme Objective

The primary investment objective of the scheme is to seek to generate consistent returns by investing in equity and equity related or fixed income securities of Pharma and other associated companies.

Nippon India Pharma Fund is a Equity - Sectoral fund launched on 5 Jun 04. It is a fund with High risk and has given a CAGR return of 20.6% since its launch.  Ranked 35 in Sectoral category.  Return for 2024 was 34% , 2023 was 39.2% and 2022 was -9.9% .

Below is the key information for Nippon India Pharma Fund

NAV as on 21 Jul 25₹522.364 ↓ -0.57  (-0.11 %)
Net Assets (AUM) as on 30 Jun 2025 ₹8,569 Cr.
Launch Date5 Jun 2004
CategoryEquity - Sectoral
Rating
TypeOpen Ended Fund
RiskHigh
AMCNippon Life Asset Management Ltd.
Alpha Ratio-2.16
Expense Ratio1.88 %
Sharpe Ratio0.566
Information Ratio-0.55
BenchmarkNot Available
Min Investment ₹5,000
Min SIP Investment ₹100
Exit Load 0-1 Years (1%),1 Years and above(NIL)

Returns

Annual Compounded Returns

Returns up to 1 year are on absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 21 Jul 25

DurationReturns
1 Month 3.3%
3 Month 7.3%
6 Month 4.9%
1 Year 12.3%
3 Year 24.2%
5 Year 21.4%
10 Year
15 Year
Since launch 20.6%

Historical Annual Returns

Historical performance (Yearly) on absolute basis

YearReturns
2024 34%
2023 39.2%
2022 -9.9%
2021 23.9%
2020 66.4%
2019 1.7%
2018 3.6%
2017 7.6%
2016 -10.6%

Growth of 10k Over Years

DateValue
30 Jun 20₹10,000
30 Jun 21₹16,184
30 Jun 22₹13,821
30 Jun 23₹16,792
30 Jun 24₹23,641
30 Jun 25₹27,501

Asset Allocation

Asset ClassValue
Cash1.42%
Equity98.58%

Sector Allocation

SectorValue
Health Care98.58%

Top Securities Holdings / Portfolio

Holdings/Securities

NameGlobal IndustryHoldingValueQuantity
Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 09 | SUNPHARMA
Drug Manufacturers - Specialty & Generic13%₹1,050 Cr6,256,349
Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB
Drug Manufacturers - Specialty & Generic9%₹793 Cr1,198,808
↓ -100,000
Lupin Ltd (Healthcare)
Equity, Since 31 Aug 08 | LUPIN
Drug Manufacturers - Specialty & Generic6%₹486 Cr2,483,991
Cipla Ltd (Healthcare)
Equity, Since 31 May 08 | CIPLA
Drug Manufacturers - Specialty & Generic6%₹469 Cr3,200,000
Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 30 Jun 11 | DRREDDY
Drug Manufacturers - Specialty & Generic5%₹458 Cr3,662,170
Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Sep 20 | APOLLOHOSP
Medical Care Facilities5%₹446 Cr648,795
Medplus Health Services Ltd (Healthcare)
Equity, Since 30 Nov 22 | 543427
Pharmaceutical Retailers4%₹351 Cr3,627,277
GlaxoSmithKline Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Aug 22 | GLAXO
Drug Manufacturers - General4%₹311 Cr943,731
↓ -68,190
Vijaya Diagnostic Centre Ltd (Healthcare)
Equity, Since 30 Sep 21 | 543350
Diagnostics & Research3%₹271 Cr2,831,564
Narayana Hrudayalaya Ltd (Healthcare)
Equity, Since 30 Jun 17 | NH
Medical Care Facilities3%₹245 Cr1,406,946
↓ -19,224
1 - 10 of 41
Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Fund Managers

NameSinceTenure
Sailesh Raj Bhan1 Apr 0520.18 Yr.
Kinjal Desai25 May 187.02 Yr.

Custodians

CompanyAddress
Deutsche Bank AGDeutsche Bank AG,Kodak House, 22, D.N. Road,

Registrar & Transfer Agent

KFin Technologies Ltd
Address138 -Suyesh Solitaire, Nr. Podar International School,Kudasan, Gandhinagar, Gujarat
FAXN.A
EmailN.A

Administrator Companies

CompanyAddress
Nippon India Mutual Fund9th Floor, Crescenzo, C-38 & 39,,G Block, Bandra Kurla Complex, Bandra (East), Mumbai 400051

Auditors

CompanyAddress
Haribhakti & Co. Chartered Accountants42, Free Press House,4th Floor,,215, Nariman Point,

All Plan & Options

Fund and PlanNAV6 Month1 Year3 Year5 Year
Nippon India Pharma Fund
Normal Dividend, Payout
₹121.75
↓ -0.13
4.06 %11.35 %23.55 %23.97 %
Nippon India Pharma Fund
Normal Dividend, Reinvestment
₹121.75
↓ -0.13
4.06 %11.35 %23.55 %23.97 %
Nippon India Pharma Fund
Growth
₹522.364
↓ -0.57
4.92 %12.28 %24.2 %21.45 %
Data as on 21 Jul 25

Disclaimer:
All efforts have been made to ensure the information provided here is accurate. However, no guarantees are made regarding correctness of data.